Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,369,945
+$326,409 QoQ
Shares Held
9,418
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,834
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026one8zero8, LLC holds $21,932,963 across 7 Drug Manufacturers - General names. ABBV ranks #2 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
58,659 | $14,897,626 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
9,418 | $2,369,945 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
33,580 | $1,934,879 | |
| 4 | LLY |
ELI LILLY & Co
|
860 | $1,031,509 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,460 | $830,110 | |
| 6 | NVS |
Novartis AG
|
2,852 | $446,965 | |
| 7 | PFE |
Pfizer Inc
|
17,522 | $421,929 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,369,945 | 9,418 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,043,536 | 9,396 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,244,914 | 9,825 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,263,303 | 9,775 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,758,563 | 9,474 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,063,562 | 9,849 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,070,027 | 11,649 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||